Medical device startups from the last five years, by category. FDA status comes from the clearance tracker where an applicant matches; funding figures are public numbers only.
Structural heart, electrophysiology, vascular access and cardiac monitoring.
Neuromodulation, brain-computer interfaces, stroke and neurodiagnostics.
Assays, point-of-care testing, sequencing and lab instruments.
All 44 →Software as a medical device, AI decision support and digital therapeutics.
All 51 →Surgical robots, navigation, instruments and energy devices.
All 36 →Implants, biologics, spine hardware and sports medicine.
All 30 →Ultrasound, MRI, CT, optical imaging and image analysis.
All 49 →CGM, insulin delivery and metabolic monitoring.
All 8 →Ventilation, sleep apnea, airway and pulmonary devices.
All 19 →Patches, wearables, home monitoring and hospital-at-home hardware.
All 41 →Fertility, maternal health, pelvic and breast health devices.
All 15 →Eye, ear, nose and throat devices and implants.
All 8 →Dental implants, aligners, imaging and chairside tools.
All 3 →Exoskeletons, prosthetics, physical therapy and assistive devices.
All 9 →Pumps, injectors, inhalers and combination products.
All 17 →Endoscopy, incontinence, kidney and gastrointestinal devices.
All 29 →Consultancies, test labs, CROs and submission specialists that serve device startups.
All 2 →Contract manufacturers, components, materials and packaging.
All 6 →Builds robotically assisted radiation therapy systems for brachytherapy and intraoperative radiation therapy. Its Vektra platform follows Sculptura, a beam-sculpting system Empyrean bought from Sensus Healthcare in 2022.
Builds airway and GI stents, cryo biopsy probes and steerable endobronchial instruments, plus molecular diagnostics for lung cancer triage. Formed under Ajax Health in 2023 and acquired Thoracent in 2025.
Robotic platform for remote endovascular procedures, pairing a bedside unit that drives guidewires and catheters with a radiation-free control suite. Also sells Inflante, a digitally controlled indeflator for balloon inflation.
Cloud-native radiology platform that combines PACS, diagnostic viewing, reporting and worklist in a single system. Also sells Sirona Cortex, an agentic AI layer for radiology workflow.
Makes EOlife, a real-time ventilation feedback device that measures the air volume delivered to a cardiac arrest patient's lungs and shows rescuers when to adjust.
Develops ophthalmic imaging hardware and AI diagnostic software, including the MIAS-3000 OCT analysis system cleared as a Class III device in China.
Builds handheld optical coherence tomography systems on a photonic chip, for retinal disease monitoring in clinics and at home.
Builds the Spandan line of smartphone-connected ECG devices for personal, clinical and institutional cardiac screening, with remote physician review.
Empyrean Medical Systems filed a 510(k) for Vektra, a robotically assisted brachytherapy and intraoperative radiation therapy system. Vektra builds on Sculptura, cleared in 2019 and bought from Sensus Healthcare for $15M in cash.
Paradromics will work with Siemens Healthineers on imaging protocols for its Connexus brain-computer interface, covering candidacy assessment through surgical navigation. Neither company disclosed financial terms.
AAO-HNSF published an updated tinnitus clinical practice guideline on October 12 with a new statement on bimodal neuromodulation. Neuromod Devices said October 16 that its De Novo authorized Lenire device is named in it.
EndoQuest Robotics named former HCA Healthcare robotics VP Jared Eben chief commercial officer on October 15. The Houston company is preparing a De Novo request for its endoluminal surgical robot and targets a US launch next year.
BioVentrix pulled the registration for a roughly $17 million Nasdaq listing it filed in February 2026. The company said the terms of the offering were never set and no securities were sold.
Siemens Healthineers has stopped selling Acuson general ultrasound carts, including the Sequoia, Redwood, Juniper and Maple. It will keep the Freestyle point-of-care probes and the Acuson Origin cardiovascular line.
Zimmer Biomet extended its exclusive distribution agreement with Think Surgical for a multi-year term, announced October 13. Zimmer sells a version of the TMINI handheld robot configured for its Persona knee system.
Boston Scientific sued Atraverse Medical in Delaware over US Patent 12,733,955, which issued September 15, 2026. The accused product is Hotwire, an RF transseptal guidewire cleared in May 2024. Johnson & Johnson bought Atraverse earlier this year.
Listing is editorial and does not imply endorsement. Companies are added from FDA filings, funding announcements, accelerator cohorts and reader tips. To add or correct a listing, send it in.
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
You're in. The next morning brief lands in your inbox.